Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge

Table 3

Chi-squared test of the efficacy of immunotherapy.

	DCR	PD	Total
Group 2	3	5	8	0.808	0.059
Group 3	17	17	34
Total	20	22	42
Group 1	6	7	13	0.813	0.056
Group 3	17	17	34
Total	23	24	47
Group 1	6	7	13	1.000	—
Group 2	3	5	8
Total	9	12	21